A Phase III development to demonstrate efficacy and safety of T121 for the treatment of patients with CRPS (Complex Regional Pain Syndrome).
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- 05 Dec 2016 New trial record